Year: 2009
Type: letter
Abstract: To the Editor:In a recent article in the Journal of Asthma, Steiß et al. report findings from a study of omalizumab in nine patients with severe allergic asthma ([1]). Consistent with previous larg...
Source: Journal of Asthma
Authors: Raymond G. Slavin, Pablo Jimenez
Institutions: Saint Louis University, Novartis (United States)
Language: English
Subfield: Physiology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funder: Novartis Pharma
OpenAlex ID: W2039899524